4KM Stock Chart & Stats
€0.09
<€0.01(2.35%)
At close: 4:00 PM EDT
€0.09
<€0.01(2.35%)
Day’s Range― - ―
52-Week Range€0.06 - €0.15
Previous CloseN/A
Volume0.00
Average Volume (3M)167.00
Market Cap
€45.06M
Enterprise Value€47.71M
Total Cash (Recent Filing)€4.16M
Total Debt (Recent Filing)€9.36M
Price to Earnings (P/E)52.4
Beta1.21
Next Earnings
Feb 02, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding655,299,900
10 Day Avg. Volume0
30 Day Avg. Volume167
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.26
Price to Sales (P/S)2.53
P/FCF Ratio25.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€36.12M
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityThe return to profitability shows that Kromek has made meaningful progress from its loss-making period and established positive earnings power. Although recent results weakened, sustained profitability over two years provides a stronger foundation for reinvestment, customer delivery, and future operating improvement.
Conservative LeverageModest debt relative to equity gives Kromek financial flexibility while it manages uneven operating performance. A conservatively levered balance sheet reduces pressure from financing obligations and leaves greater scope to support product development, customer programmes, and recovery without relying heavily on additional borrowing.
Broad Radiation Technology ApplicationsKromek’s radiation detection technology addresses several end markets rather than a single application, including security, defence, medical imaging, and industrial uses. This breadth can support a more durable customer base and allow detector components, modules, and integrated solutions to benefit from varied long-term demand.
Bears Say
Revenue ContractionA 28.3% annual revenue decline indicates that demand or delivery timing has recently weakened materially, interrupting the company’s growth trajectory. If this contraction persists, lower scale would make it harder to absorb operating costs, fund development, and convert Kromek’s technology portfolio into consistent growth.
Margin CompressionThe sharp reduction in gross and net margins shows that recent sales are generating substantially less profit than in the prior year. Persistent margin pressure would reduce the earnings benefit of future revenue, weaken internal funding capacity, and make results more sensitive to product mix and execution.
Volatile Cash ConversionFree cash flow remained positive, but its 84.4% year-over-year decline after strong 2025 generation highlights unreliable cash conversion. Such volatility can constrain discretionary investment and make it more difficult for Kromek to fund development, absorb working-capital needs, or consistently support operations from internally generated cash.
Kromek Group plc News
4KM FAQ
What was Kromek Group PLC’s price range in the past 12 months?
Kromek Group PLC lowest stock price was €0.06 and its highest was €0.15 in the past 12 months.
What is Kromek Group PLC’s market cap?
Kromek Group PLC’s market cap is €45.06M.
When is Kromek Group PLC’s upcoming earnings report date?
Kromek Group PLC’s upcoming earnings report date is Feb 02, 2027 which is in 101 days.
How were Kromek Group PLC’s earnings last quarter?
Kromek Group PLC released its earnings results on Sep 14, 2026. The company reported -€0.005 earnings per share for the quarter.
Is Kromek Group PLC overvalued?
According to Wall Street analysts Kromek Group PLC’s price is currently Overvalued.
Does Kromek Group PLC pay dividends?
Kromek Group PLC does not currently pay dividends.
What is Kromek Group PLC’s EPS estimate?
Kromek Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kromek Group PLC have?
Kromek Group PLC has 655,299,900 shares outstanding.
What happened to Kromek Group PLC’s price movement after its last earnings report?
Kromek Group PLC reported an EPS of -€0.005 in its last earnings report. Following the earnings report the stock price went down -3.896%.
Which hedge fund is a major shareholder of Kromek Group PLC?
Currently, no hedge funds are holding shares in DE:4KM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kromek Group plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.71%
12-Months-Change
Fundamentals
Return on Equity
1.32%
Trailing 12-Months
Asset Growth
-5.04%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Kromek Group PLC
Kromek Group plc, a UK-based entity established in 2013 with headquarters in Sedgefield, specializes in the design, production, and global distribution of advanced radiation detection components and devices. These technologies provide high-resolution data on material composition and structure, serving critical applications across diverse markets such as medical imaging, the civil nuclear sector, CBRNe security, and safety screening. Its reach extends across the United Kingdom, North America, Asia, Europe, Australasia, and Africa. The company's innovative solutions are employed for various purposes, from identifying cancerous tissues and hazardous substances like explosives, to analyzing radioactive materials. Within the civil nuclear industry, Kromek offers sophisticated gamma and neutron detectors, high-specification, high-resolution devices, essential components, and specialized software designed to address complex nuclear detection challenges. These often utilize cadmium zinc telluride (CZT) or scintillator technologies for the detection of gamma rays, x-rays, and neutrons. For medical imaging, their portfolio includes CZT gamma detectors for SPECT, CZT bone mineral densitometry detectors, and cutting-edge photon-counting spectral CT systems. Kromek also provides CBRNE homeland security products and comprehensive solutions for a wide range of clients, including government agencies, border control, airports, seaports, HazMat teams, ambulance crews, police, and armed forces. This offering features specialized gamma spectroscopy software for in-depth sample analysis. Furthermore, the company supports scientific research and development through its CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array, designed for laboratory and research applications. Kromek distributes its products through a combination of distributors, original equipment manufacturers (OEMs), and direct sales channels.